Chemicals and pharmaceuticals · MREO

Mereo BioPharma Group plc

5 filings mentioning 7 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

5filings we hold
7topics disclosed
Chemicals and pharmaceuticalsindustry
X0based in

Across 5 filings we hold, Mereo BioPharma Group plc has written down 7 of the topics we track. That places it 586 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

MREO Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something Mereo BioPharma Group plc has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ISO 22301:201938
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
AICPA Privacy Management Framework (PMF)22
ISO/IEC 27701:201921
Australian Privacy Principles (APPs)19
DORA19
NIST SP 800-16115

10 frameworks, 309 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Privacy Compliance3
Ransomware3
Third Party Risk Management3
Internal Control1
Material Weakness1
Restatement1
Business Continuity1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Privacy Compliance32026-03-19
Ransomware32026-03-19
Third Party Risk Management32026-03-19
Internal Control12024-06-14
Material Weakness12024-06-14
Restatement12024-11-12
Business Continuity12026-03-19

When it filed

Filings we hold, by year. Hover a bar for the count.

24
25
26

Recent filings

FiledFormItem
2026-03-1910-Kfiling
2025-03-2610-Kfiling
2024-11-128-KEntry into a material agreement, Results of operations, the earnings release, Financial statements and exhibitsfiling
2024-06-148-KEntry into a material agreement, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-03-2710-Kfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition